The frequency of adverse effects remains unclear. Adverse effects vary depending on the route of administration.

The ophthalmic solution may correlate with transient burning of eyes upon administration, eye dryness, puffiness, irritation, itchiness, rash, and styes.

Adverse reactions reported with the cromolyn sodium nasal spray were nasal congestion, sneezing, nasal itching, nosebleeds, rhinoconjunctivitis, and headaches.

Adverse reactions reported with the inhalation solution were throat irritation and hoarseness, esophagitis, laryngeal and pharyngeal edema, drowsiness, dizziness, bronchial irritation, pulmonary infiltrates, and cough.

Most of the adverse reactions reported in patients with mastocytosis have been transient and can be symptoms of the disease. The most frequently reported adverse reactions in patients with mastocytosis who received oral cromolyn sodium solution in clinical studies were headache, diarrhea, pruritus, nausea, myalgia, abdominal pain, rash, and irritability. In addition, adverse events associated with oral solution include vomiting, constipation, erythema, photosensitivity, urticaria, and angioedema. Additionally, reported adverse reactions in clinical studies for patients with other conditions and postmarketing experience were infrequent, and attribution to cromolyn could not be determined. Most of these reports are of dyspepsia, constipation,  glossitis, flatulence, stomatitis, vomiting, dysphagia, and esophagospasm.